Labeler
Horizon Therapeutics USA, Inc. NDC Codes
Horizon Therapeutics USA, Inc. lists 12 finished drug products in the FDA NDC Directory under NDC labeler code 75987.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Active ingredients
- Cysteamine bitartrate, Pegloticase, Sodium phenylbutyrate, Inebilizumab, Teprotumumab, Interferon gamma-1b, Glycerol phenylbutyrate
- NDC labeler codes
- 75987
- Strengths
- Cysteamine bitartrate 75 mg/1; Pegloticase 8 mg/50mL; Inebilizumab 10 mg/mL; Cysteamine bitartrate 300 mg/1; Teprotumumab 500 mg/1; Interferon gamma-1b 100 ug/.5mL; Cysteamine bitartrate 25 mg/1; Glycerol phenylbutyrate 1.1 g/mL; Pegloticase 8 mg/mL; Sodium phenylbutyrate 500 mg/1; Sodium phenylbutyrate .94 g/g
- Dosage forms
- Injection, Solution, Granule, Delayed release, Capsule, Delayed release pellets, Injection, Injection, Powder, Lyophilized, For solution, Liquid, Tablet, Powder
- Routes
- Oral, Intravenous, Subcutaneous
- Drug classes (FDA established)
- Cystine Depleting Agent, Nitrogen Binding Agent, Uric Acid-specific Enzyme, CD19-directed Cytolytic Antibody, Insulin-like Growth Factor-1 Receptor Inhibitor, Interferon gamma
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 15
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Krystexxapegloticase | Pegloticase 8 mg/50mL | Injection, SolutionIntravenous | 75987-058 | 75987-0058-01 | — |
| Upliznainebilizumab | Inebilizumab 10 mg/mL | InjectionIntravenous | 75987-150 | 75987-0150-03 | — |
| Procysbicysteamine bitartrate | Cysteamine bitartrate 75 mg/1 | Granule, Delayed releaseOral | 75987-140 | 75987-0140-1375987-0140-14 | — |
| Procysbicysteamine bitartrate | Cysteamine bitartrate 300 mg/1 | Granule, Delayed releaseOral | 75987-145 | 75987-0145-1375987-0145-14 | — |
| Tepezzateprotumumab | Teprotumumab 500 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 75987-130 | 75987-0130-15 | — |
| Actimmuneinterferon gamma-1b | Interferon gamma-1b 100 ug/.5mL | Injection, SolutionSubcutaneous | 75987-111 | 75987-0111-11 | — |
| Procysbicysteamine bitartrate | Cysteamine bitartrate 25 mg/1 | Capsule, Delayed release pelletsOral | 75987-100 | 75987-0100-04 | — |
| Procysbicysteamine bitartrate | Cysteamine bitartrate 75 mg/1 | Capsule, Delayed release pelletsOral | 75987-101 | 75987-0101-08 | — |
| Ravictiglycerol phenylbutyrate | Glycerol phenylbutyrate 1.1 g/mL | LiquidOral | 75987-050 | 75987-0050-0675987-0050-07 | — |
| Krystexxapegloticase | Pegloticase 8 mg/mL | Injection, SolutionIntravenous | 75987-080 | 75987-0080-10 | — |
| Buphenylsodium phenylbutyrate | Sodium phenylbutyrate 500 mg/1 | TabletOral | 75987-060 | 75987-0060-08 | — |
| Buphenylsodium phenylbutyrate | Sodium phenylbutyrate .94 g/g | PowderOral | 75987-070 | 75987-0070-09 | — |
Horizon Therapeutics USA, Inc.: common questions
- What is Horizon Therapeutics USA, Inc.'s NDC labeler code?
- 75987. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Horizon Therapeutics USA, Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.